BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38870959)

  • 1. Direct-to-consumer microbiome testing needs regulation.
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2024 Jul; 9(7):583. PubMed ID: 38870959
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct-to-consumer Genetic Testing: Changes in the EU Regulatory Landscape.
    Slokenberga S
    Eur J Health Law; 2015 Dec; 22(5):463-80. PubMed ID: 26665691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-to-Consumer Genetic Testing and Potential Loopholes in Protecting Consumer Privacy and Nondiscrimination.
    Hendricks-Sturrup RM; Prince AER; Lu CY
    JAMA; 2019 May; 321(19):1869-1870. PubMed ID: 30998825
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of the legislation of direct-to-consumer genetic testing in EU member states.
    Hoxhaj I; Stojanovic J; Sassano M; Acampora A; Boccia S
    Eur J Med Genet; 2020 Apr; 63(4):103841. PubMed ID: 31923586
    [No Abstract]   [Full Text] [Related]  

  • 5. The DTC microbiome testing industry needs more regulation.
    Hoffmann DE; von Rosenvinge EC; Roghmann MC; Palumbo FB; McDonald D; Ravel J
    Science; 2024 Mar; 383(6688):1176-1179. PubMed ID: 38484067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consumer Perspectives on Access to Direct-to-Consumer Genetic Testing: Role of Demographic Factors and the Testing Experience.
    Gollust SE; Gray SW; Carere DA; Koenig BA; Lehmann LS; McGUIRE AL; Sharp RR; Spector-Bagdady K; Wang NA; Green RC; Roberts JS;
    Milbank Q; 2017 Jun; 95(2):291-318. PubMed ID: 28589610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Food and drug administration's regulatory shift on direct-to-consumer genetic tests for cancer risk.
    Yang YT; Zettler PJ
    Cancer; 2019 Jan; 125(1):12-14. PubMed ID: 30387874
    [No Abstract]   [Full Text] [Related]  

  • 8. [Direct-to-consumer genetic testing: a regulation by the market, or a medical regulation?].
    Jautrou H
    Med Sci (Paris); 2020 Feb; 36(2):153-159. PubMed ID: 32129752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulating Direct-to-Consumer Polygenic Risk Scores.
    Sherkow JS; Park JK; Lu CY
    JAMA; 2023 Aug; 330(8):691-692. PubMed ID: 37535347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New EU Rules for In Vitro Diagnostic Genetic Tests, a First Step in the Right Direction.
    Roscam Abbing HDC
    Eur J Health Law; 2017 Apr; 24(2):121-33. PubMed ID: 29210257
    [No Abstract]   [Full Text] [Related]  

  • 11. Growing complexity of (expanded) carrier screening: Direct-to-consumer, physician-mediated, and clinic-based offers.
    Chokoshvili D; Vears DF; Borry P
    Best Pract Res Clin Obstet Gynaecol; 2017 Oct; 44():57-67. PubMed ID: 28302443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advantages and disadvantages of direct-to-consumer genetic tests].
    Christiansen CW; Gerdes AA
    Ugeskr Laeger; 2017 Mar; 179(11):. PubMed ID: 28330535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients Armed With Their Own Genetic Data Raise Tough Questions.
    Storrs C
    Health Aff (Millwood); 2018 May; 37(5):690-693. PubMed ID: 29733706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-to-consumer teledermatology services for pediatric patients: Room for improvement.
    Fogel AL; Teng J; Sarin KY
    J Am Acad Dermatol; 2016 Nov; 75(5):887-888. PubMed ID: 27614530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed to consumer genetic testing. Perspective from the Ethics commission of the Spanish Society for Human Genetics.
    Pàmpols Ros T; García Sagredo JM; Pérez Aytés A; Díaz de Bustamante A
    Med Clin (Barc); 2019 Jul; 153(1):35-40. PubMed ID: 30898448
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.
    Gill J; Obley AJ; Prasad V
    JAMA; 2018 Jun; 319(23):2377-2378. PubMed ID: 29800087
    [No Abstract]   [Full Text] [Related]  

  • 17. Gut microbiota: a target for intervention in obesity.
    Sehgal K; Khanna S
    Expert Rev Gastroenterol Hepatol; 2021 Oct; 15(10):1169-1179. PubMed ID: 34329563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. “Better Not to Know?”: Justifiable Limits on the Right to Information in the Realm of DTC Genetic Testing. An Analysis of the European and Spanish Legal Framework.
    Martínez Otero JM
    Eur J Health Law; 2017 Apr; 24(2):175-97. PubMed ID: 29210260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct-to-Consumer Genetic Testing: Finding a Clear Path Forward.
    Seward B
    Ther Innov Regul Sci; 2018 Jul; 52(4):482-488. PubMed ID: 29714553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of modulating the gastrointestinal microbiota in cancer patients.
    Morkūnas E; Skiecevičienė J; Kupčinskas J
    Best Pract Res Clin Gastroenterol; 2020; 48-49():101700. PubMed ID: 33317795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.